Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net income (loss)	$ 2,635	$ (1,565)	$ 501
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Unrealized foreign currency exchange gain, net	(5)	0	0
Depreciation and amortization expense	1,119	1,011	932
Share-based compensation expense	205	140	110
Non-cash interest expense	26	19	51
Amortization of debt discount and debt issuance costs	57	72	114
Reduction of right-of-use assets	607	393	291
Loss on modification or extinguishment of debt	66	116	217
Total losses on derivative instruments, net	6,531	5,989	211
Net cash used for settlement of derivative instruments	(904)	(1,579)	74
Loss on equity method investments	55	24	126
Deferred taxes	440	(715)	40
Repayment of paid-in-kind interest related to repurchase of convertible notes	(13)	(190)	(911)
Other, net	11	9	8
Changes in operating assets and liabilities:
Trade and other receivables, net of current expected credit losses	(502)	(799)	(154)
Inventory	(123)	(409)	21
Margin deposits	631	(741)	(13)
Other current assets	67	(101)	(14)
Accounts payable and accrued liabilities	250	1,144	54
Total deferred revenue	124	55	(23)
Total operating lease liabilities	(622)	(418)	(277)
Other, net	(132)	14	(93)
Net cash provided by operating activities	10,523	2,469	1,265
Cash flows from investing activities
Property, plant, and equipment	(1,830)	(966)	(1,839)
Proceeds from sale of fixed assets	1	68	0
Investment in equity method investment	(15)	0	(100)
Other, net	0	(14)	(8)
Net cash used in investing activities	(1,844)	(912)	(1,947)
Cash flows from financing activities
Proceeds from issuances of debt	1,575	5,911	7,823
Redemptions and repayments of debt	(6,771)	(6,810)	(6,940)
Debt issuance and other financing costs	(51)	(53)	(125)
Debt modification or extinguishment costs	(28)	(82)	(172)
Distributions to non-controlling interest	(947)	(649)	(626)
Payments related to tax withholdings for share-based compensation	(63)	(48)	(43)
Repurchase of common stock	(1,373)	(9)	(155)
Dividends to stockholders	(349)	(85)	0
Payments of finance lease liabilities	(7)	0	0
Other, net	0	8	3
Net cash used in financing activities	(8,014)	(1,817)	(235)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	5	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents	670	(260)	(917)
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period	1,817	2,077	2,994
Cash, cash equivalents and restricted cash and cash equivalents—end of period	$ 2,487	$ 1,817	$ 2,077